




Modern Trends in Kidney Transplantation 
T. E. Starzl, R. Weil, and C. W. Putnam 
I T IS OBVIOUS that the so-called 
modern trends in kidney transplanta-
tion represent an evolution based on actual 
experience that began about 15 years ago 
and from which much of a very practical 
nature has been learned. To trace the de-
velopment of the present-day attitudes and 
practices, we reviewed the results and ad-
justments in our own program, which began 
in 1962, obtaining follow-ups on all the 556 
consecutive patients treated at the Uni-
versity of Colorado from 1962 until 1 year 
ago. In addition, we surveyed the abstracts 
on renal transplantation submitted to this 
year's program committee of the Transplan-
tation Society in order to gain insight into 
what was perceived as important by others 
working in this field. 
COLORADO CASE MATERIAL 
During the 13 years from 1962 to 1975, 
our program has profited from the efforts of 
many talented members of this society, a 
number of whom now run their own units 
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elsewhere. The direct involvement of the 
senior author (T.E.S.) ceased almost com-
pletely in the summer of 1972. From 1972 
to 1974, Drs. Jacques Corman (now of 
Montreal) and Bo Husberg (now in Malmo) 
directed the effort on a locem tenens basis 
of 1 year each. The directorship was filled 
(by R.W.) in the summer of 1974. These 
arrangements illustrate an important trend 
worth noting; namely, that major input by 
a well· trained chief is obligatory for the suc-
cess of a kidney transplant program. At-
tempts to -maintain transplant sideshows 
without such a major commitment have 
usually failed. 
The features of each of seven periods in 
our renal transplantation program are sum-
marized in Table I in terms of immuno-
suppression. The cases in the first five series 
encompassing the decade 1962-1972 have 
been reported beforeKl~ Double-drug 
therapy with azathioprine and prednisone 
was used until 1966. Since then, triple-
agent therapy including antilymphocyte 
. globulin (ALG) has been employed. In 
series 5, cyclophosphamide was substituted 
for azathioprine during the first several 
postoperative months. Although the results 
were not different than with azathioprine, 
we have returned to the routine use of 
azathioprine because of our much greater 
experience with the latter drug and because 
of our high degree of satisfaction with its 
use. 
The cases were consecutive. At the be-
ginning, an effort was made to treat younger 
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Table 1. Experience With Renal Transplantation at the University of Colorado, 1962-1975 
Number of Co ... Follow·Up 
Series Related Unrelated" Date. (Yean) Main Feature 
1 46 18 November 1962 to March 1964 121-131 Azathioprine/prednisone; good risk 
2 25 23 Odober 1964 to April 1966 101-11 t Azathioprine/prednisone + typing; good risk 
3 60 17 June 1966 to February 1968 81-101 Azathioprine/prednisone/AlG; good risk 
4 122 15 March 1968 to March 1971 51- 81 Azathioprine/prednisone/ALG; all risk' 
5 •• 28 March 1971 to August 1972 4- 51 Cyclophosphamide/prednisone/ALG; all risk 
6 65 49 August 1972 to August 197. 2- • Azathioprine/prednisone/ALG; all risk 
7 27 17 September 197. to August 1975 1- 2 Azathioprine/prednisone/ALG; all risk 
'Since late 1965. all unrelated kidneys have come from cadavers. Before then. non related volunteer donors were used. 
organ systems. About 7 years ago, the con-
ditions for transplantation were relaxed to 
permit the treatment of older recip;ents and 
of patients with concomitant diabetes 'melli-
tus, coronary heart disease, previous 
malignancies, and a variety of other dis-
orders that had previously been considered 
contraindications. 
from 67% to 61%, and between the 5- and 
lO-year interval it declined to 52%. To put it 
differently, a patient in the consanguineous 
series 1 who lived for a year had an 80% 
chance of surviving a decade. Two more 
Table 2. Actual Survival at 1 Year and Thereafter 




The genuine therapeutic potential of con-
sanguineous transplantation was evident 
from 1962 to 1975. Even in series 1, com-
piled 121 to almost 14 years ago, two-thirds 
ofthe recipients of related kidneys lived for 
at least I year (Fig. 1 and Table 2). Between 
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TIME IN YEARS 
1962 to 1975 
Per cent Survival 
Number of 2 4 8 10 
Co ... Year Yean Yean Yean Yean 
46 67 65 61 57 52 
25 64 64 52 .0 .0 
60 92 88 78 67 
122 76 73 68 
« 86 80 74 
65 77 75 
27 89 
Fig. 1. Ufe survival curves of patients 
treated with primary related homografts 
during five intervals from 1962 to the 
summer af 1972. Arrow. show time of 
minimum follow-up. Description of series 




Table 3. Number of Survivors in Related Series With Functioning 
Original Transplants or Subsequent Grafts 
Present 
Series Time Following Survivors· 
1 1O~-1Pi 22/46 (48%) 
2 101-1 11 10/25 (40%) 
3 84-101 40/60 (67%) 
4 54- 81 75/122 (61%; 
5 4- 51 33/44 (75%) 
6 2- 4 49/65 (75%) 
7 1- 2 22/27 (81%) 
• July 1976. 
deaths occurred in the 11th and 12th post-
operative years so that today 22 (48%) of 
the original 46 original recipients are alive. 
The mortality of the original patients 
averaged throughout the full period of ob-
servation has been almost exactly 4% per 
year. 
The related kidneys have proved to be 
highly durable. After a minimum follow-up 
of 12 ~ years, 18 of the 22 present survivors 
in series I still have good function of their 
original transplants (Table 3). Two more 
are living on second grafts and one is living 
on a fifth graft. Both of the second trans-
plants that now have been functioning for 
more than 8 years were donated by parents 
when a primary kidney from the other 
parent was rejected after more than 5 years. 
The second to fifth retransplants in the 
other recipient were from cadavers. Only 
one patient is anephric (Table 3). Renal 
function ceased in this case more than II 
years after receipt of a cousin's kidney, 
when immunosuppressive treatment had to 
be stopped because of systemic crypto-
coccosis. 
Subsequent Series 
An attempt in series 2 to select donors by 
prospective tissue typing 5 was not fruitful~ 
since the pattern of heavy early and lighter 
delayed mortality was not altered. After 
1M~ to almost 12 years, 10 (40%) of these 
25 consanguineous recipients are still alive, 
7 with the original kidneys. 
- A reduction in early mortality was ob-
tained in series 3, begun in 1966. The I-year 
OoOr;g;ool Successful Aft.r 
Graft Retransplontation Anephric 
18 3 
7 2 1 
30 8 2 
67 6 2 
28 4 1 
40 6 3 
16 0 6 
survival in that series of a decade ago rose 
to 92%. After 8, to 10 years, 67% of these 
patients are still alive (Fig. I and Table 2) 
for an average loss from the original popu-
lation of about 3.5% per year. Series 3 was 
the last one in which candidacy was generally 
restricted to good-risk recipients. Although 
the restrictions were relaxed in series 4 and 
5, the I-year survivals were 76% and 86%, 
respectively, with a similar gradual sub-
sequent loss rate (Fig. I and Table 2). The 
results in series 6 and 7 are probably going 
to follow tne same-pattern (Table 2). 
In series 2-6, the need for retransplanta-
tion has been approximately the same as in 
series 1 (Table 3), and only a handful of the 
surviving patients in these groups are 
anephric (Table 3). This reflects an aggres-
sive policy of retransplantation in our 
center. 
NONRELATED TRANSPLANT AnON 
Series J 
Although the majority of recipients of re-
'lated kidneys survived chronically even in 
1962 and 1963, the same was not true if un-
related kidneys were used. 
The I-year mortality after unrelated 
transplantation in our series I was 67% 
(Fig. 2 and Table 4). By 5 years, only 2 
(11%) of an original 18 recipients were still 
alive. Both patients still survive after 12, 
and 13 years, but only one has an original 
graft. That exceptional organ (in a patient 
identified in past publications by the code 
LD 63) is probably the longest functioning 
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Fig. 2. Life survival curves after trans-
plantation of non related kidneys during the 
same five time periods as in Fig. 1. Descrip-
tion of series is in Table 1. Arrows show 
time of minimum followoup. 
234567891011 
TIME IN YEARS 
Table 4. Actual Survival at 1 Year and Thereafter 
in Patients Given Primary Nonrelated Grafts cr~m 
1962 to 1975 
Number Per tent Survival 
of 2 4 8 10 
Series Cases Year Yeors Years Yeors Yeors 
18 33 22 17 11 11 
2 23 52 43 30 17 13 
3 17 82 76 41 29 
4 15 80 80 80 
5 28 75 75 61 
6 49 82 71 
7 17 94 
The other patient who remains alive (LD 
54) now has a well-functioning cadaveric 
graft after rejecting first a kidney from a 
nonrelated living donor and next a trans-
plant of maternal origin. Five of the 13 
years of his survival have been on dialysis. 
Subsequent Series 
A substantial and lasting improvement of 
survival for recipients of nonrelated kidneys 
was late in coming in our experience. In 
series 2, which was completed in April 
1966, the I-year survival was upgraded to 
52%, but after 5 years only 5 (22%) of 23 
patients were alive. Now after 1O! to almost 
12 years, only 3 (13%) are left, in 2 cases 
with original kidneys. In series 3, in which 
12 13 
all of our nonrelated organs were obtained 
from :;adavers, the I-year survival had in-
creased (Fig. 2 and Table 4) to 82% (14 of 
17). Unfortunately, deaths continued at a 
steady rate so that at 5 years only 6 (35;;.) 
of the recipients of series 3 were left. Now o 
after U~ to 10 years, 5 (29%) remain. In 4 of 
these 5 survivors of series 3, the original 
cadaveric kidneys are still functioning. In 
the combined nonrelated series 1-3, the 
average actual patient loss rate over the first 
decade after transplantation was the un-
acceptable figure of approximately U~D-;; of 
the original population per year. 
However, beginning in 1968 and con-
tinuing throughout series 4 and 5, patient 
survival sharply improved throughout the 
first 4 or 5 years and beyond (Fig. 2 and 
Table 4). Three-fourths or more of the re-
cipients were alive at I year and from then 
until 4 and 5 years, the further deaths were 
reduced. However, a different attitude 
about the primacy of the transplants was 
obvious. Now, the grafts were being aban-
doned, and the patients were being treated 
by return to dialysis and aggressive re-
transplantation. For example, in series 4 
after a minimum follow-up of almost 6 years., 
73% of the original patient group (II of 15) 
are still alive but only 4 of the II have 
original cadaveric grafts. Five others have 
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Table 5. Number of Survivors in Nonrelated Series With functioning 
Original Transplants or Subsequent Grafts 
Series Time following Survivors 
121-13 2/18 (11%) 
2 101-111 3/23 (13%) 
3 8l-101 5/17 (29%) 
4 51- 81 11/15 (73%) 
5 4- 51 17/28 (61%) 
6 2-4 32/49 (65%) 
7 1- 2 14/17 (82%) 
lad successful retransplantation, and two 
He back on dialysis (Table 5). 
From all of the first six periods of our ex-
'erience, relatively few surviving patients 
re anephric. In the nonrelated series 1-6, 
nly 10 of the 70 surviving patients are 
nephric. Thus, the potential administra-
ve spectre of developing a pool of non-
ansplantable recipients by virtue of un-
lccessful primary transplantation has not 
a terialized. 
The improved survival after cadaveric 
IOspla.Hation has been maintained in the 
)re recent series 7 (Table 4). 
CAUSES OF DEATH AFTER 5 YEARS 
fwenty-four patients from series \-4 died 
m 60 to 137 months after their original 
ney transplants. A study of their fate 
,vided insight about the late risks that are 
to be encountered in future cases. Nine 
,hese 24 recipients had undergone re-
lsplantation after failure of the primary 
ley. In 16 of the 24 cases, renal function 
'1 a primary or secondary graft was still 
1 uate just before the final illness. 
le single most common delayed lethal 
H was pneumonitis caused by a virus in 
cases, Pneumocystis carinii in one case, 
J mixed bacterial flora in the other. 
of the six patients who died of pneu-
tis were healthy with function of the 
lal transplant until the fatal acute 
:.Jtory crisis. The other two had failed 
ling kidneys and both had recently 
~one retransplantation. Two other pa-
died with complications of dis-
ltl!d cy toml!ga lovirus infections. 
On Original Succe .. ful After 
Graft Retran.plantation Anephric 
1 0 
2 0 1 
.. 1 0 
.. 5 2 
11 5 
20 6 6 
8 5 
Four other patients, all with well-func-
tioning renal hO!JIografts, died of chronic 
aggressive hepatitis. Thus, kidney trans-
plantation under today's circumstances is 
generating candidates for liver transplanta-
tion. Among our own renal recipients who 
died of hepatic failure, consideration of 
liver transplantation was delayed for too 
long. However, we have attempted liver and 
kidney transplantation for combined 
hepatic and renal failure in one renal re-
cipient who was referred from another cen-
ter. The pat.ient died 5 weeks postopera-
tively .. 
Three patients committed suicide, one by 
stopping medication, one by refusing to re-
turn to dialysis, and the third by shotgun 
. injury. The other causes of late death are 
self-explanatory (Table 6). One patient died 
Table 6. Causes of Death 5 Years or More After 
Primary Kidney Transplantation 
Number 01 Patients 
With Adequate 
Number of Antemortem 
Causes 01 Death Patients Kidney function 
Pneumonia 6 4 
Liver failure 4 .. 
Me.entric vascular 
occlusion 3 2 
Suicide 3 
Disseminated CMV 
infection 2 1 
Coronary occlusion 2 2 
Colan perforation 2 
Cancer 
Hyperparathyroidism and 
skin gangrene 0 
Total 24 16 
6 
or disseminated carcinoma of the jaw: two 
more whose deaths were caused by a 
mesenteric infarction and pneumonitis, 
respectively, had an incidental carcinoma 
of the lung and a hepatoma. The fact that 
only one late death was caused by malig-
nancy was encouraging in view of the in-
cidence of de novo malignancies that has 
been reported at about 10% in our chronic 
survivors.4 The low death rate from tumors 
reflects the effectiveness of the cancer 
therapy that can be applied in immuno-
suppressed recipients, especially if repeated 
and careful examinations are made by 
physicians who are conscious that this is a 
special problem. ' 
Three patients eventually died from 
mesenteric vascular occlusion (two arterial 
and one venous) and bowel necrosis. An ab-
normal incidence of vascular disease was· 
also reflected in two deaths from myo-
cardial infarction. Finally, a patient with 
hyperparathyroidism developed widespread 
metastatic calcification in small vessels 
and consequent massive skin and sub-
cutaneous fat infarction. Another of our 
recipients survived a less severe variant of 
this dreadful complication but at the price 
of more than a year's continuous hospitali-
zation and only after the amputation of 
both hands and forearms. 
NOT AllON OF TRENDS 
The trends in our own experience are 
also easy to identify in most other programs 
today. This is not surprising. since es-
sentially all of the immunosuppressive and 
other techniques being used now have been 
generally available for a decade or more. 
The failure of radically new methods to be 
developed in the last 8-10 years has rele-
gated progress to the shuffling of details and 
to the adjustment of earlier attitudes and 
policies. 
F or one thing, there has been a recogni-
tion of the impermanence of nonrelated 
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kidneys compared to consanguineous or-
gans. At the International Transplantation 
Conferences convened by the New York 
Academy of Sciences in 1964 and 1966, 
there was much talk that cadaveric organs 
that were functioning well at 1 or 2 years 
would probably be good for a decade. Our 
results and those of many others have 
shown this expectation to be unrealistic. 
Fortunately, the conditions for treat-
ment of renal failure have also changed, 
making possible a second shift in attitude 
about both cadaveric and consanguineous 
transplantation. Throughout the 1960s, 
transplantation was usually carried out on' a 
research ward as a desperate administra-
tive alternative to the financial ruin caused 
by the necessity for prolonged dialysis. 
The prospect of homograft failure with re-
turn to dialysis was a grim and unacceptable 
one for many people. Consequently, ag-
gressive immunosuppressive treatment was 
too often persisted in after all reasonable 
hope had been lost for continuing graft 
function. This was the main explanation 
for the high mortality in our cadaveric 
series 1-3. In recent years, the proper inter-
locking, as opposed to competing, roles of 
dialysis and transplantation have been 
recognized and exploited. In large part this 
was made possible by the Federal H.R. I 
Bill amending Medicare-Medicaid. This 
legislation provided the necessary financial 
backing for complete treatment. The new 
ground rules have permitted either trans-
plantation or dialysis to be considered part 
of the same continuum of care for renal 
failure in which the transition from one to 
the other modality is of minimum economic 
concern. 
The mortality should be less and the 
quality of life should be greater with com-
bined dialysis and transplantation than 
with either treatment alone. The data from 
our experience suggest that a patient today 




TRENDS IN KIDNE1I' TRANSPlANTATION 
have about a 15% chance of living at least 
5 years if either.a related or unrelated trans-
plantation is periormed, providing there is a 
willingness to abandon and remove failed 
grafts early, especially cadaveric ones. The 
risks of dialysis alone are probably greater 
than this, as kCl'S been exemplified by the 
Public Health Service collected statistics 
showing a 4-year dialysis mortality of about 
40%.6 
It is self-evident that neither technique is 
perfect for chronic care. However, it is 
recognized that the causes of late death are 
somewhat different in transplant and 
dialysis recipieMs. The profound suscepti-
bility of dialysis patients to vascular disease 
and to neuroi.ogic complications is well 
known, whereas the chief causes of late 
death after tra1y~plantation will probably 
continue to be infections (mainly affecting 
the lungs and liver) and possibly malig-
nancy in the long run. The imperfections 
of both transplantation and dialysis are 
underscored by the high incidence of sui-
cide and serious emotional disorders in 
patients treated by either method. . 
Efforts to impr,ave transplantation are re-
flected in the abstracts for this year's pro-
gram, and from these more trends that are 
worth mentioning can be seen. Typing is 
not dead, as was illustrated by a total of 
. about two dozen abstracts with variable but 
generally fuzzy correlations of HL-A match 
and outcome and better correlations with 
MLC tests. The effects of chronic dialysis 
and transfusions prior to transplantation 
were said to be usually not harmful. Most 
authors conceded that preformed recipient 
antibodies were prognostically bad even 
without demonstrable antidonor specificity. 
Efforts to make the treatment on·a ra-
tional rather than an empirical basis were 
illustrated by many abstracts directly con-
cerned with preoperative or postoperative 
monitoring, most commonly with im-
munologic measures, but also with other 
7 
sophisticated techniques such as radio-
nuclide scanning. A smalJ number of papers 
was concerned with further defining patho-
logic changes in rejecting grafts or with the 
physiologic performance of transplants. 
The subject of organ preservation was 
covered in II abstracts. For 2- or 3-day 
periods, the perfusion methods pioneered 
by Belzer were shown to have a demon-
strable advantage. But from a practical 
point of view, the simple flush techniques of 
Collins and Sacks have yielded about com-
parable results providing transplantation 
could be completed within 24-36 hr. The 
result hiS been a-movement away from the 
perfusion approach. 
The dead-center position of imm-uno-
suppression was evident from the fact that 
almost all the clinical abstracts concerned 
with rejection therapy were reexaminations 
of older techniques. Questioned were the 
value of graft irradiation, the value of anti-
lymphocyte globulin, the usefulness of al-
ternating day steroid therapy, and the 
efficacy of high-dose pulse steroid adminis-
tration. 
At the same time, the sometimes devasta-
ting effectiveness of all forms of treatment 
now in use was attested to by 22 abstracts 
. detailing the complications of chronic im-
munosuppression. These included cancer; 
gastrointestinal ulcerations; viral, bacterial, 
and fungal infections; hypersplenism; 
hyperparathyroidism; cataracts; bone 
disease; liver malfunction; hyperlipidemia; 
and vascular disease. The central objective 
of research in our specialty remains the 
achievement of graft acceptance with lesser 
penalties than are now exacted. 
SUMMARY 
Trends in renal transplantation stem 
from recognition of the virtues and draw-
backs of this kind of treatment and from a 
better appreciation of the interrelationship 
between transplantation and dialysis. 
8 STARZl, WEll, AND PUTNAM 
REFERENCES 
I. Starzl TE: Experience in Renal Transplantation. 
Philadelphia, W.B. Saunders, 1964 
2. Starzl TE, Putnam CW: Experience in Hepatic 
Transplantation. Philadelphia, W.B. Saunder. 1969, 
pp 242-266 
3. Starzl TE, Putnam CW, Halgrimson CG. et al: 
Surg Gynecol Obstet 133:981. 1971 
4. Starzl TE. Porter KA. Husberg BS. et al: In 
Ravitch MM (cd): Current Problems in Surg"ery" 
Chicago, Year Book. Part I, pp I-59; Part II, pp I-54. 
1974 
5. Terasaki PI. Porter KA, Marchioro TL. et al: 
Ann NY Acad Sci 129:500. 1966 
6. Report on National Dialysis Regulations. 
Seventh Annual Contractors Conference, January 
28-30. 1974. DHEW Publication No. NIH 75.248, 
1974 
